Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $285,468.00 |
|---|---|
| Enterprise Value | $3.19 Million |
| Earnings per Share | $-0.06 |
| Beta | 1.33 |
| Outstanding Shares | 28,546,834 |
| P/E Ratio | -0.16 |
|---|---|
| PEG | -0.83 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.96 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.92 |
| Debt to Equity | -0.77 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
NEXT-ChemX Corporation owns ion targeting membrane extraction technology in the United States. The company's technology mimics nature biophysical processes enabling the technology to extract ions from a liquid solution at ambient tempera...